Rinkey Investments’s Medifast MED Stock Holding History

Rinkey Investments’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-15	Closed	-$3K	–	157
2021 Q4	$3K	Buy	+15	New	+$3.1K	﹤0.01%	213

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Rinkey Investments's MED Position: Q1 2022 in Review

Rinkey Investments sold out of Medifast (MED) in Q1 2022, closing a stake of 15 shares — an estimated $3K sold.

Rinkey Investments first reported a position in MED in Q4 2021 and held it in 1 quarter. The position peaked at $3K in Q4 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.

Rinkey Investments reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
Rinkey Investments sold 15 Medifast shares in Q1 2022, an estimated $3K.
Rinkey Investments first reported a position in Medifast in Q4 2021 and held it in 1 quarter.
Rinkey Investments's Medifast position peaked at $3K in Q4 2021.
288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.

Based on Rinkey Investments's 13F filing for Q1 2022, filed 9 May 2022.